Search

Home > High Intensity Health Radio with Mike Mutzel > Obesity , Leptin & Risk of Autoimmunity: a Problem in Achieving Herd Immunity
Podcast: High Intensity Health Radio with Mike Mutzel
Episode:

Obesity , Leptin & Risk of Autoimmunity: a Problem in Achieving Herd Immunity
Category: Health
Duration: 00:21:30
Publish Date: 2021-11-11 02:16:33
Description:

Scientists find lean subjects made protective antibodies after infection while obese subjects did not make protective antibodies—they made maladaptive autoantibodies instead. Researchers speculate that leptin plays a role in skewing the immune response toward autoimmunity after infection. Here's the details!

Related: Save your seat in the upcoming Blood Work MasterClass Live Training

RSVP Here: https://courses.highintensityhealth.com/store/hgwDdo2p

Research, Images and Articles: https://bit.ly/3qsGYX6

Time Stamps:

0:00 Intro 0:09 Endemic Virus 0:59 Obese Don't Make Protective Antibodies 1:15 Obese people make autoantibodies 1:40 Leptin and Fat on Fire 2:40 Leptin exacerbates inflammation, autoimmunity 3:13 Study we're discussing 3:49 Make Americans Healthy Again 4:35 Blood Work MasterClass 5:30 Daniela Frasca, PhD: Obesity Hinders Immune System Response 6:10 Antibodies and BMI, C-Reactive Protein 6:43 Metainflammation and Inflammaging 7:15 Blood sugar and inflammation 8:13 Leptin and immunity 9:29 Summary of Study: immune tolerance breakdown 11:30 Lifestyle matters 12:30 Antibodies directed at fat tissue 12:52 Omega-6 Oils, Seed Oils & autoimmunity 13:50 Excess deaths related to heart disease on the rise 14:42 Image: CRP and autoantibodies 15:39 New study summary 16:21 Italy Research from fat cell spill over 16:58 Obesity is an autoimmune disease 17:05 Change your habits 17:47 Image: Behavior model

Books and References:

Tiny Habits: The Small Changes That Change Everything: https://amzn.to/3CbpvEQ

Frasca, D., Reidy, L., Cray, C., Diaz, A., Romero, M., Kahl, K., & Blomberg, B. B. (2021). Influence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients. Plos One, 16(3), e0245424–16.

 

Frasca, D., Reidy, L., Romero, M., Diaz, A., Cray, C., Kahl, K., & Blomberg, B. B. (2021). The majority of SARS-CoV-2-specific antibodies in COVID-19 patients with obesity are autoimmune and not neutralizing. International Journal of Obesity, 1–6.
Total Play: 0